IMS Health Holdings Company Profile (NYSE:IMS)

About IMS Health Holdings (NYSE:IMS)

IMS Health Holdings logoIMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: IT Services & Consulting
  • Sub-Industry: N/A
  • Symbol: NYSE:IMS
  • CUSIP: N/A
  • Web:
Average Prices:
  • 50 Day Moving Avg: $31.34
  • 200 Day Moving Avg: $30.95
  • 52 Week Range: $23.71 - $31.34
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.91
  • P/E Growth: 0.00
  • Net Margins: 2.99%
  • Return on Equity: 5.62%
  • Return on Assets: 1.22%
  • Debt-to-Equity Ratio: 2.53%
  • Current Ratio: 1.12%
  • Quick Ratio: 1.12%
  • Beta: 0.83

Frequently Asked Questions for IMS Health Holdings (NYSE:IMS)

What is IMS Health Holdings' stock symbol?

IMS Health Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMS."

How were IMS Health Holdings' earnings last quarter?

IMS Health Holdings Inc (NYSE:IMS) announced its quarterly earnings data on Wednesday, July, 27th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.03. The firm had revenue of $802 million for the quarter, compared to analysts' expectations of $796.93 million. IMS Health Holdings had a net margin of 2.99% and a return on equity of 5.62%. The business's revenue for the quarter was up 112.4% on a year-over-year basis. During the same period last year, the firm earned $0.37 earnings per share. View IMS Health Holdings' Earnings History.

Who are some of IMS Health Holdings' key competitors?

How do I buy IMS Health Holdings stock?

Shares of IMS Health Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IMS Health Holdings' stock price today?

One share of IMS Health Holdings stock can currently be purchased for approximately $31.34.

MarketBeat Community Rating for IMS Health Holdings (NYSE IMS)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  261
MarketBeat's community ratings are surveys of what our community members think about IMS Health Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for IMS Health Holdings (NYSE:IMS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for IMS Health Holdings (NYSE:IMS)
Price Target History for IMS Health Holdings (NYSE:IMS)
Analysts' Ratings History for IMS Health Holdings (NYSE:IMS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
5/4/2016Topeka Capital MarketsBoost Price TargetBuy$29.00 -> $30.00N/AView Rating Details
3/24/2016Piper Jaffray CompaniesReiterated RatingOverweight$28.00 -> $32.00N/AView Rating Details
2/23/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
2/4/2016J P Morgan Chase & CoLower Price Target$38.00 -> $32.00N/AView Rating Details
2/4/2016Barclays PLCLower Price TargetEqual Weight$28.00 -> $26.00N/AView Rating Details
2/2/2016Deutsche Bank AGLower Price TargetBuy$30.00N/AView Rating Details
10/30/2015MizuhoLower Price TargetBuy$36.00 -> $33.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for IMS Health Holdings (NYSE:IMS)
Earnings by Quarter for IMS Health Holdings (NYSE:IMS)
Earnings History by Quarter for IMS Health Holdings (NYSE IMS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2016Q216$0.38$0.41$796.93 million$802.00 millionViewListenView Earnings Details
5/3/2016Q116$0.38$0.42$749.34 million$774.00 millionViewN/AView Earnings Details
2/3/2016Q415$0.32$0.37$788.75 million$812.00 millionViewN/AView Earnings Details
10/29/2015Q315$0.32$0.38$740.98 million$735.00 millionViewListenView Earnings Details
4/24/2015Q115$0.31$0.38$626.89 million$632.00 millionViewN/AView Earnings Details
2/3/2015Q414$0.32$0.34$679.82 million$678.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.33$0.37$668.30 million$656.00 millionViewListenView Earnings Details
7/24/2014Q1$0.37$0.39$654.92 million$662.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for IMS Health Holdings (NYSE:IMS)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.75 EPS


Dividend History for IMS Health Holdings (NYSE:IMS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for IMS Health Holdings (NYSE:IMS)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 90.25%
Insider Trades by Quarter for IMS Health Holdings (NYSE:IMS)
Institutional Ownership by Quarter for IMS Health Holdings (NYSE:IMS)
Insider Trades by Quarter for IMS Health Holdings (NYSE:IMS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/23/2015Kevin C. KnightlySVPSell19,231$28.50$548,083.50View SEC Filing  
11/19/2015Kevin C. KnightlySVPSell55,000$28.37$1,560,350.00View SEC Filing  
5/12/2015Cpp Investment Board Private HMajor ShareholderSell30,554,584$26.68$815,196,301.12View SEC Filing  
4/9/2014Cpp Investment Board Private HMajor ShareholderSell11,990,976$19.10$229,027,641.60View SEC Filing  
4/9/2014John G DanhaklDirectorSell2,463,899$20.00$49,277,980.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for IMS Health Holdings (NYSE:IMS)
Latest Headlines for IMS Health Holdings (NYSE:IMS)
DateHeadline logoQuintiles IMS Holdings’ (Q) Shares Have Buy Rating Remain in Place - October 6 at 2:57 AM logoQuintilesIMS to Host Financial Analyst and Investor Conference on November 8, 2017 - October 4 at 5:23 PM logoWhy You Need To Look At This Factor Before Buying Quintiles IMS Holdings Inc (Q) - October 2 at 11:12 PM logoHead-To-Head Review: Total System Services (TSS) and IMS Health Holdings (IMS) - September 23 at 6:30 AM logoQuintilesIMS Announces Pricing on Offering of Senior Notes - September 11 at 8:28 PM logoQUINTILES IMS HOLDINGS, INC. - September 11 at 8:28 PM logoQuintiles IMS Incorporated -- Moody's rates Quintiles IMS's new Euro notes Ba3 - September 11 at 8:28 PM logoQuintiles Transnational Corp. -- Moody's assigns Ba1 rating to QuintilesIMS' term loan B; Ba2 CFR affirmed; outlook revised to negative - September 6 at 7:47 PM logoOxford Immunotec Appoints Stefan Linn as Chief Operating Officer - August 31 at 6:09 AM logoOxford Immunotec (OXFD) Names Stefan Linn as New COO - August 31 at 6:09 AM logoDrug Giants Are Hunting for Patients in India's Remote Corners - August 2 at 11:24 PM logoQuintilesIMS to Announce Second-Quarter 2017 Results on August 3, 2017 - July 20 at 11:39 PM logoFortune 500 co. sells Houston health tech co. following revenue slide - July 19 at 3:26 AM logoEQT to acquire pharmaceutical services firm Certara - July 12 at 4:52 AM
News IconEQT nears deal to acquire pharma services firm Certara: sources - July 12 at 4:52 AM logoPAVmed Inc. Closes $5 Million Financing - July 6 at 5:55 AM logoBiopharma Outsourcing Is Going Through Deal Bonanza in U.S. - June 21 at 3:36 PM logoPamplona Capital to take Parexel private for $4.5 bln - June 20 at 6:47 PM logoPamplona Capital to take Parexel private for $4.5 billion - June 20 at 6:47 PM logoQuintilesIMS (Q) Approves Additional $1B Buyback - May 24 at 5:50 PM logoQuintilesIMS to Announce First-Quarter 2017 Results on May 3, 2017 - April 19 at 5:46 PM logoCover Story: Inside one of Triangle's hottest industries – CROs - March 10 at 7:06 PM logoQuintilesIMS releases first earnings report as a combined company - February 14 at 7:17 PM logoAcademics call time on $100,000 cancer drugs - February 9 at 6:51 PM logoLonza agrees to buy Capsugel in $5.5 billion deal - December 15 at 4:40 AM logoLonza nearing $5 bln deal for KKR's Capsugel - December 12 at 10:55 AM logoDrug-Research Firm PPD Explores Sale - Wall Street Journal - December 9 at 3:32 PM logoHealthcare Tech Stocks With Upside Growth Potential - PR Newswire (press release) - December 1 at 5:57 PM logoForm 8-K Quintiles IMS Holdings, For: Nov 29 - - November 30 at 9:35 AM logoThe Big Q: Life after Quintiles-IMS merger - November 25 at 10:51 AM



IMS Health Holdings (IMS) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.